Literature DB >> 24215913

HCV infection selectively impairs type I but not type III IFN signaling.

Partha K Chandra1, Lili Bao1, Kyoungsub Song1, Fatma M Aboulnasr1, Darren P Baker2, Nathan Shores3, William C Wimley4, Shuanghu Liu5, Curt H Hagedorn5, Serge Y Fuchs6, Tong Wu1, Luis A Balart3, Srikanta Dash7.   

Abstract

A stable and persistent Hepatitis C virus (HCV) replication cell culture model was developed to examine clearance of viral replication during long-term treatment using interferon-α (IFN-α), IFN-λ, and ribavirin (RBV). Persistently HCV-infected cell culture exhibited an impaired antiviral response to IFN-α+RBV combination treatment, whereas IFN-λ treatment produced a strong and sustained antiviral response that cleared HCV replication. HCV replication in persistently infected cells induced chronic endoplasmic reticulum (ER) stress and an autophagy response that selectively down-regulated the functional IFN-α receptor-1 chain of type I, but not type II (IFN-γ) or type III (IFN-λ) IFN receptors. Down-regulation of IFN-α receptor-1 resulted in defective JAK-STAT signaling, impaired STAT phosphorylation, and impaired nuclear translocation of STAT. Furthermore, HCV replication impaired RBV uptake, because of reduced expression of the nucleoside transporters ENT1 and CNT1. Silencing ER stress and the autophagy response using chemical inhibitors or siRNA additively inhibited HCV replication and induced viral clearance by the IFN-α+RBV combination treatment. These results indicate that HCV induces ER stress and that the autophagy response selectively impairs type I (but not type III) IFN signaling, which explains why IFN-λ (but not IFN-α) produced a sustained antiviral response against HCV. The results also indicate that inhibition of ER stress and of the autophagy response overcomes IFN-α+RBV resistance mechanisms associated with HCV infection.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24215913      PMCID: PMC3873489          DOI: 10.1016/j.ajpath.2013.10.005

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.

Authors:  Partha K Chandra; Anup K Kundu; Sidhartha Hazari; Sruti Chandra; Lili Bao; Tara Ooms; Gilbert F Morris; Tong Wu; Tarun K Mandal; Srikanta Dash
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

2.  Autophagy is activated for cell survival after endoplasmic reticulum stress.

Authors:  Maiko Ogata; Shin-ichiro Hino; Atsushi Saito; Keisuke Morikawa; Shinichi Kondo; Soshi Kanemoto; Tomohiko Murakami; Manabu Taniguchi; Ichiro Tanii; Kazuya Yoshinaga; Sadao Shiosaka; James A Hammarback; Fumihiko Urano; Kazunori Imaizumi
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

Review 3.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

4.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

5.  Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.

Authors:  Tobias Marcello; Arash Grakoui; Giovanna Barba-Spaeth; Erica S Machlin; Sergei V Kotenko; Margaret R MacDonald; Charles M Rice
Journal:  Gastroenterology       Date:  2006-10-01       Impact factor: 22.682

6.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Authors:  Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

7.  A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.

Authors:  Mei Wang; Wanloo Tan; Jin Zhou; Jolene Leow; Meilin Go; How Sung Lee; Patrick J Casey
Journal:  J Biol Chem       Date:  2008-04-23       Impact factor: 5.157

Review 8.  Epidemiology of hepatitis C virus infection.

Authors:  Miriam J Alter
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

Review 9.  Mammalian nucleoside transporters.

Authors:  Wei Kong; Karen Engel; Joanne Wang
Journal:  Curr Drug Metab       Date:  2004-02       Impact factor: 3.731

10.  Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon.

Authors:  Sidhartha Hazari; Lizeth Taylor; Salima Haque; Robert F Garry; Sander Florman; Ronald Luftig; Frederic Regenstein; Srikanta Dash
Journal:  Virol J       Date:  2007-09-18       Impact factor: 4.099

View more
  38 in total

Review 1.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

2.  IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism.

Authors:  Daisaku Yamada; Sumera Rizvi; Nataliya Razumilava; Steven F Bronk; Jaime I Davila; Mia D Champion; Mitesh J Borad; Jorge A Bezerra; Xin Chen; Gregory J Gores
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

3.  Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling.

Authors:  Abigail Jarret; Adelle P McFarland; Stacy M Horner; Alison Kell; Johannes Schwerk; MeeAe Hong; Samantha Badil; Rochelle C Joslyn; Darren P Baker; Mary Carrington; Curt H Hagedorn; Michael Gale; Ram Savan
Journal:  Nat Med       Date:  2016-11-14       Impact factor: 53.440

4.  Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.

Authors:  Rajesh Panigrahi; Partha K Chandra; Pauline Ferraris; Ramazan Kurt; Kyoungsub Song; Robert F Garry; Krzysztof Reiss; Imogen R Coe; Tomomi Furihata; Luis A Balart; Tong Wu; Srikanta Dash
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

Review 5.  Roles of autophagy in HIV infection.

Authors:  Christina Dinkins; Manohar Pilli; John H Kehrl
Journal:  Immunol Cell Biol       Date:  2014-11-11       Impact factor: 5.126

6.  Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression.

Authors:  Pauline Ferraris; Partha K Chandra; Rajesh Panigrahi; Fatma Aboulnasr; Srinivas Chava; Ramazan Kurt; Jean-Michel Pawlotsky; Ludwig Wilkens; Pamela Osterlund; Rune Hartmann; Luis A Balart; Tong Wu; Srikanta Dash
Journal:  Am J Pathol       Date:  2016-02-16       Impact factor: 4.307

7.  Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection.

Authors:  Feyza Gunduz; Chaithanya Mallikarjun; Luis A Balart; Srikanta Dash
Journal:  Exp Mol Pathol       Date:  2013-11-08       Impact factor: 3.362

8.  Chaperone-Mediated Autophagy Promotes Beclin1 Degradation in Persistently Infected Hepatitis C Virus Cell Culture.

Authors:  Yucel Aydin; Christopher M Stephens; Srinivas Chava; Zahra Heidari; Rajesh Panigrahi; Donkita D Williams; Kylar Wiltz; Antoinette Bell; Wallace Wilson; Krzysztof Reiss; Srikanta Dash
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

Review 9.  Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy.

Authors:  Daniela Ploen; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 10.  Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis.

Authors:  Srikanta Dash; Yucel Aydin; Tong Wu
Journal:  Semin Cell Dev Biol       Date:  2019-08-08       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.